TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Key Developments

• In January 2022, TensCare, a manufacturer and distributor of TENS machines, participated in the ABHI UK Pavilion at Arab Health 2022. It showcased its newest products, featuring advanced transcutaneous electrical nerve stimulation (TENS) technology. TENS is widely recognized for drug-free pain relief, beneficial in treating chronic conditions like diabetic neuropathy, back pain, sciatica, osteoarthritis, and acute childbirth pain. Additionally, TensCare presented its range of electrotherapy devices designed to enhance muscle toning and address issues such as bladder weakness and incontinence.
• In April 2020, Synapse Biomedical obtained Emergency Use Authorization (EUA) from the U.S. FDA for its TransAeris, a diaphragm stimulator aiding COVID-19 patients in transitioning from mechanical ventilation. As global COVID-19 recoveries increase, there is anticipated growth in the demand for TransAeris and similar devices in homecare settings, likely boosting market expansion in the foreseeable future.
• In April 2020, OMRON Healthcare, Inc., a global company in personal heart health and wellness technology, introduced Focus TENS Therapy for Knee. This new addition to its pain management products utilize transcutaneous electrical nerve stimulation (TENS) technology in a sleek, wearable device. It offers wireless capabilities and customizable relief for chronic, arthritic, and acute pain related to exercise strain or daily activities.